Switch to:
GuruFocus has detected 3 Warning Signs with Cardiovascular Systems Inc $CSII.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Cardiovascular Systems Inc (NAS:CSII)
EV-to-EBITDA
-345.41 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Cardiovascular Systems Inc's enterprise value is $923.6 Mil. Cardiovascular Systems Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2017 was $-2.7 Mil. Therefore, Cardiovascular Systems Inc's EV/EBITDA ratio for today is -345.41.

CSII' s EV-to-EBITDA Range Over the Past 10 Years
Min: -359.4   Max: 6.7
Current: -345.38

-359.4
6.7

During the past 13 years, the highest EV/EBITDA Ratio of Cardiovascular Systems Inc was 6.70. The lowest was -359.40. And the median was -11.90.

CSII's EV-to-EBITDA is ranked lower than
99.99% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. CSII: -345.38 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Cardiovascular Systems Inc's stock price is $31.10. Cardiovascular Systems Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.23. Therefore, Cardiovascular Systems Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Cardiovascular Systems Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=923.637/-2.674
=-345.41

Cardiovascular Systems Inc's current Enterprise Value is $923.6 Mil.
Cardiovascular Systems Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2017 was -3.945 (Jun. 2016 ) + -0.103 (Sep. 2016 ) + 2.089 (Dec. 2016 ) + -0.715 (Mar. 2017 ) = $-2.7 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Cardiovascular Systems Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=31.10/-0.23
=

Cardiovascular Systems Inc's share price for today is $31.10.
Cardiovascular Systems Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2017 was -0.15 (Jun. 2016 ) + -0.06 (Sep. 2016 ) + 0.03 (Dec. 2016 ) + -0.05 (Mar. 2017 ) = $-0.23.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Cardiovascular Systems Inc Annual Data

Dec07Dec08Jun09Jun10Jun11Jun12Jun13Jun14Jun15Jun16
ev2ebitda -1.390.48-4.07-2.49-26.51-12.81-21.25-25.67-24.87-10.39

Cardiovascular Systems Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
ev2ebitda -27.30-35.94-24.87-12.45-9.66-4.91-10.39-18.17-30.400.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK